CVRx (CVRX) Gains from Investment Securities (2020 - 2021)
CVRx's (CVRX) quarterly Gains from Investment Securities came in at -$1.8 million in Q3 2021, down 398.92% year-on-year from $617558.8 in Q3 2020, and down 116.12% quarter-over-quarter from $11.5 million in Q2 2021.
CVRx (CVRX) Gains from Investment Securities (2020 - 2021) Analysis & Trends
CVRx's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$1.8 million for Q3 2021.
- On a quarterly basis, Gains from Investment Securities fell 398.92% year-over-year to -$1.8 million in Q3 2021; TTM through Jun 2022 was -$1.8 million, a 111.89% decrease from a year earlier, with the FY2021 full-year figure at $13.3 million, up 3483.29% from the prior year.
- Gains from Investment Securities eased to -$1.8 million in Q3 2021 per CVRX's latest filing, from $11.5 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $11.5 million in Q2 2021 and bottomed at -$1.8 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | CVRx | 125.98 Mn | 53.68 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.85 Mn |
| Sep 30, 2021 | -1.85 Mn |
| Jun 30, 2021 | 11.45 Mn |
| Jun 30, 2021 | 11.45 Mn |
| Mar 31, 2021 | 3.69 Mn |
| Mar 31, 2021 | 3.69 Mn |
| Dec 31, 2020 | 758,000.00 |
| Dec 31, 2020 | 758,000.00 |
| Sep 30, 2020 | -370,000.00 |
| Sep 30, 2020 | -370,000.00 |